EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for …

…, B Bannwarth, JWJ Bijlsma, P Dieppe… - Annals of the …, 2003 - ard.bmj.com
Objectives: To update the EULAR recommendations for management of knee osteoarthritis
(OA) by an evidence based medicine and expert opinion approach. Methods: The literature …

Osteoarthritis: new insights. Part 1: the disease and its risk factors

DT Felson, RC Lawrence, PA Dieppe… - Annals of internal …, 2000 - acpjournals.org
Osteoarthritis is the most common form of arthritis, affecting millions of people in the United
States. It is a complex disease whose etiology bridges biomechanics and biochemistry …

Pathogenesis and management of pain in osteoarthritis

PA Dieppe, LS Lohmander - The Lancet, 2005 - thelancet.com
The term osteoarthritis describes a common, age-related, heterogeneous group of disorders
characterised pathologically by focal areas of loss of articular cartilage in synovial joints …

Developing and evaluating complex interventions: the new Medical Research Council guidance

P Craig, P Dieppe, S Macintyre, S Michie, I Nazareth… - Bmj, 2008 - bmj.com
Developing and evaluating complex interventions: the new Medical Research Council
guidance Page 1 Developing and evaluating complex interventions: the new Medical …

Developing and evaluating complex interventions: the new Medical Research Council guidance.

P Craig, P Dieppe, S Macintyre, S Michie, I Nazareth… - 2013 - psycnet.apa.org
Comments on the editorial by Peter Griffiths & Ian Norman (see record 2013-10991-001).
The editorial summarized many important points. The Medical Research Council guidance …

Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.

MC Hochberg, RD Altman, KD Brandt… - Arthritis and …, 1995 - europepmc.org
A comment on this article appears in" Fluoroscopically directed steroid instillation in the
treatment of hip osteoarthritis: safety and efficacy in 510 cases." Arthritis Rheum. 2001 Oct; …

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

P Jüni, L Nartey, S Reichenbach, R Sterchi, PA Dieppe… - The lancet, 2004 - thelancet.com
Background The cyclo-oxygenase 2 inhibitor rofecoxib was recently withdrawn because of
cardiovascular adverse effects. An increased risk of myocardial infarction had been …

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including …

A Pendleton, N Arden, M Dougados… - Annals of the …, 2000 - ard.bmj.com
BACKGROUND Osteoarthritis (OA) is the most common joint disease encountered
throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in …

What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected …

…, V Wylde, R Gooberman-Hill, A Blom, P Dieppe - BMJ open, 2012 - bmjopen.bmj.com
Background Total hip or knee replacement is highly successful when judged by prosthesis-
related outcomes. However, some people experience long-term pain. Objectives To review …

All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study

E Nüesch, P Dieppe, S Reichenbach, S Williams, S Iff… - Bmj, 2011 - bmj.com
Objective To examine all cause and disease specific mortality in patients with osteoarthritis
of the knee or hip. Design Population based cohort study. Setting General practices in the …